| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 67,249 | 67,016 | 71,340 | 73,641 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 67,249 | 67,016 | 71,340 | 73,641 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,021 | 3,889 | 3,658 | 4,165 | | Non Recurring | 107 | (107) | 3,460 | 34,191 | | Others |
-
|
-
| 162 | (101) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 63,121 | 63,234 | 64,060 | 35,386 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 107 |
-
|
-
| 6 | | Earnings Before Interest And Taxes | 63,228 | 63,234 | 64,060 | 35,392 | | Interest Expense | 29,198 | 32,493 | 42,281 | 44,411 | | Income Before Tax | 34,030 | 30,741 | 21,779 | (9,019) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 34,030 | 30,741 | 21,779 | (9,019) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (170) | 7,638 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,030 | 30,741 | 21,609 | (1,381) | | Preferred Stock And Other Adjustments | (1,482) | (1,482) | (1,482) | (1,482) | | | Net Income Applicable To Common Shares | $32,548 | $29,259 | $20,127 | ($2,863) |
|
0.01% Nasdaq 0.00%
Income Statement
